BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2318584)

  • 1. Reduction of basement membrane thickening in diabetic cat retina by sulindac.
    Mansour SZ; Hatchell DL; Chandler D; Saloupis P; Hatchell MC
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):457-63. PubMed ID: 2318584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
    Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus.
    Hainsworth DP; Katz ML; Sanders DA; Sanders DN; Wright EJ; Sturek M
    Comp Med; 2002 Dec; 52(6):523-9. PubMed ID: 12540165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA; Anderson HR; Stitt AW
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased numbers of caveolae in retinal endothelium and pericytes in hypertensive diabetic rats.
    Hillman N; Cox S; Noble AR; Gallagher PJ
    Eye (Lond); 2001 Jun; 15(Pt 3):319-25. PubMed ID: 11450729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice.
    Steinle JJ; Kern TS; Thomas SA; McFadyen-Ketchum LS; Smith CP
    Exp Eye Res; 2009 Jun; 88(6):1014-9. PubMed ID: 19176214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericyte coverage of retinal and cerebral capillaries.
    Frank RN; Turczyn TJ; Das A
    Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):999-1007. PubMed ID: 2354923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Zheng Z; Chen H; Xu X; Li C; Gu Q
    Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retinal vascular lesions in diabetic retinopathy].
    Crăiţoiu S; Mocanu C; Olaru C; Rodica M
    Oftalmologia; 2005; 49(1):82-7. PubMed ID: 15934345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats.
    Chakrabarti S; Sima AA
    Diabetes; 1989 Sep; 38(9):1181-6. PubMed ID: 2504638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug.
    Gardiner TA; Anderson HR; Degenhardt T; Thorpe SR; Baynes JW; Archer DB; Stitt AW
    Diabetologia; 2003 Sep; 46(9):1269-75. PubMed ID: 12861449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal capillary basement membrane thickness in spiny mice (Acomys cahirinus) with induced and spontaneous diabetes.
    Beauchemin ML; Leuenberger PM; Babel J
    Invest Ophthalmol; 1975 Jul; 14(7):560-2. PubMed ID: 124711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.
    Frank RN; Keirn RJ; Kennedy A; Frank KW
    Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1519-24. PubMed ID: 6642931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy.
    Robison WG; Jacot JL; Katz ML; Glover JP
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):109-20. PubMed ID: 10803422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
    Nagata M; Robison WG
    Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant retinal capillary basement membrane thickening in hyperglycemic and normoglycemic diabetic-prone (DP) BB Wistar rats.
    Greenwood MD; Ressler MJ; Audette JL; Laturnus DI; Chhoun R; Teiken JM; Carlson EC
    Ultrastruct Pathol; 2011 Apr; 35(2):97-105. PubMed ID: 21299351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
    Robison WG; Kador PF; Akagi Y; Kinoshita JH; Gonzalez R; Dvornik D
    Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase and retinal capillary basement membrane thickening.
    Robison WG; Nagata M; Kinoshita JH
    Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.